Results 201 to 210 of about 4,347,639 (355)
Take Five: harmonization in personalized cancer vaccines for cancer immunotherapy. [PDF]
Cho S, Lee J, Lee YM, Nam JH.
europepmc +1 more source
Albumin-binding nanobody cancer vaccines coordinate lymphatic T cell priming and inflammatory remodeling of the tumor microenvironment [PDF]
John T. Wilson +19 more
openalex +1 more source
Regulatory harmonization: Evolution, globalization and future directions
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm +2 more
wiley +1 more source
ABSTRACT Extracellular vesicles (EVs) are nanoscale membrane‐bound structures that play a pivotal role in intercellular communication by transporting bioactive molecules, including proteins, lipids, nucleic acids, and organelles, between cells. Originating from the endosomal pathway, EVs reflect the physiological and pathological status of their parent
Emine İncilay Torunoğlu +3 more
wiley +1 more source
Recent Advances in Lipid Nanoparticles for Cancer Vaccines: From Antigen Delivery to Personalized Immunotherapy. [PDF]
Rachamala HK, Angom RS, Marepally S.
europepmc +1 more source
ABSTRACT Virus‐like particles (VLPs) are a promising modality with extensive applications in prophylactic and therapeutic vaccine design. Human Papillomavirus (HPV) vaccines are one such example where VLP vaccine applications have led to the successful reduction in HPV‐associated diseases, such as cervical cancer.
Nicholas Samuelson +5 more
wiley +1 more source
Therapeutic Cancer Vaccines: Mechanisms, Clinical Progress, and Future Directions. [PDF]
Wilson K +4 more
europepmc +1 more source

